Spravato vs TMS

Published July 14, 2026 Last updated September 10, 2026

When evaluating advanced interventions for treatment-resistant depression, comparing Spravato vs TMS offers patients two distinct, FDA approved pathways to neurological recovery. Spravato is a prescription esketamine nasal spray administered under clinical supervision, whereas transcranial magnetic stimulation (TMS) is a non-invasive, non-pharmacological procedure that uses magnetic pulses to stimulate prefrontal cortex activity.

Why is Spravato vs TMS a critical comparison for patients?

For individuals who have not found relief from traditional oral antidepressants, the choice between advanced psychiatric interventions can feel overwhelming. In real-world training environments for mental health clinicians, understanding the clinical mechanism of Spravato vs TMS is essential for guiding patients toward the most suitable therapeutic option. Both treatments target neural pathways involved in mood regulation, yet they do so through entirely different biological routes.

Evaluating these options requires a clear understanding of their processes, commitments, and safety guidelines. Just as safety standards are critical in emergency response coordination, clinical safety standards are paramount when administering advanced psychiatric therapies.

Prerequisites for advanced depression care

Before a patient can begin either treatment, several strict clinical prerequisites must be met. For Spravato, patients must have a documented history of major depressive disorder that has not responded to at least two different oral antidepressants. Additionally, because Spravato is regulated under a federal Risk Evaluation and Mitigation Strategy (REMS) program, patients must concurrently take a daily oral antidepressant throughout their course of treatment.

For TMS, the criteria are similar. Clinical evaluations must confirm a diagnosis of treatment-resistant depression. Because TMS utilizes a powerful magnetic coil placed against the scalp, patients must not have any conductive or ferromagnetic metals implanted in or near their head: such as cochlear implants, aneurysm clips, or deep brain stimulators.

What most students struggle with in clinical psychiatric training is understanding how these criteria are strictly enforced. Standard guidelines require a thorough review of a patient’s historical records to ensure they meet all clinical criteria before any treatment can be authorized. Understanding the fundamental chemistry of the medication is also vital, and patients frequently ask is Spravato the same as ketamine to clarify how esketamine differs from traditional ketamine compounds.

Clinical safety and vigilance protocols

Safety is a core priority for both treatments. Because Spravato can cause temporary sedation, dissociation, and a sharp spike in blood pressure, patients must remain in the office for a mandatory two hour post administration observation period. During this window, clinical staff maintain constant vigilance, utilizing medical monitoring equipment to track vital signs.

TMS sessions do not require a recovery window or sedation. However, the protocol still demands structured monitoring. Technicians must observe patients for any signs of discomfort or rare side effects, such as a localized headache or muscle twitching. The clinical staff must also have emergency rescue protocols established in the rare event of a seizure, which is the most serious, albeit highly uncommon, risk associated with magnetic brain stimulation.

Staff qualifications and skills verification

The administration of these advanced treatments is restricted to certified healthcare professionals. Clinicians who supervise Spravato sessions must undergo specialized REMS training. This ensures they are prepared to handle potential side effects: including extreme dissociative states where a patient might feel entirely disconnected from their body. This dissociative experience is sometimes compared to an emotional submersion, requiring a calm, supportive clinical environment.

Similarly, TMS operators must complete rigorous training on the specific medical devices they operate. This training includes precise physical measurements to locate the patient’s motor cortex, establishing the “motor threshold” that determines the magnetic intensity used during sessions. In-person skills verification is mandatory for both therapies to ensure that technicians can accurately position the magnetic coil and respond to any adverse reactions. When considering where to receive these specialized services, locating accredited Spravato clinics ensures that the facility complies with all required safety standards and federal staffing qualifications.

What are the structural differences between these protocols?

To understand how these therapies fit into a patient’s life, it is helpful to look at their schedules, durations, and administrative demands. The table below compares these advanced clinical protocols against industry minimums to highlight the depth of care required.

Protocol comparison table

Feature	Spravato REMS Protocol	TMS Standard Protocol	Industry Minimum Standards
Administration Method	Supervised self administered nasal spray	Non invasive magnetic pulse coil on scalp	Generic oral antidepressant therapy
Initial Phase Frequency	Twice weekly for 4 weeks	5 days per week for 6 weeks	Once daily self administered at home
Session Duration	At least 2 hours (observation required)	19 to 40 minutes (no downtime)	Less than 5 minutes
Clinical Supervision	Direct observation by REMS certified staff	Trained TMS technician present	None (unsupervised home use)
Emergency Protocols	On-site monitoring, hypertensive rescue	Seizure management, coil calibration	Standard emergency instructions

Treatment step checklist

To give you a clear picture of what a patient experiences during a typical treatment course, here is a step-by-step checklist:

A licensed provider reviews clinical history, confirms treatment resistance, and rules out any contraindications.

The clinical administrative team coordinates with the patient’s insurance company to secure coverage approval.

Providers establish baseline scores using standardized depression rating scales and record initial vital signs.

For Spravato: The patient self administers the nasal spray under direct supervision and rests for 120 minutes.
For TMS: The patient sits in a treatment chair while the magnetic coil delivers rapid pulses to the target brain area.

Providers perform regular symptom checks and adjust schedules based on patient response.

Upon completion of the acute phase, the clinical team establishes a maintenance schedule or transition plan.

How do treatment duration and maintenance work?

A major differentiator in the discussion of Spravato vs TMS is how long the therapeutic effects last and what the long-term schedule looks like. Unlike traditional therapies that are taken indefinitely, both of these options are structured as acute courses with distinct endpoints, followed by customized maintenance plans.

Certification and protocol validity

The structured nature of these treatments means that clinic certifications must be kept up-to-date. Clinics must renew their REMS enrollment and undergo regular audits to ensure compliance with federal safety guidelines. This is similar to how medical certifications require periodic renewal to verify that staff are trained in the latest safety standards.

If a clinic fails to maintain its certification validity, it cannot order or administer the nasal spray, which highlights the critical role of continuous administrative compliance. When researching clinical options, analyzing data regarding the Spravato success rate can provide valuable information regarding long term clinical effectiveness and remission statistics.

Recertification and maintenance phases

For Spravato, the initial induction phase lasts for four weeks with twice weekly sessions. If the patient shows a positive response, they transition to a maintenance phase, which typically involves weekly sessions for another four weeks, eventually tapering to once every one to two weeks.

For TMS, the standard course is 36 sessions: delivered five days a week for six consecutive weeks, followed by a six session taper over three weeks. Once this course is finished, many patients experience sustained remission for several months or even years. If symptoms begin to re-emerge, a patient can undergo a recertification process with their insurance provider to authorize a repeat course of TMS.

What are the biological mechanisms of action?

The biological pathways targeted by these two options represent different philosophies in neurobiology. Spravato targets chemical neurotransmission, while TMS utilizes physical energy to stimulate electrical activity in the brain.

Chemistry and neural stimulation

Spravato works primarily by targeting N-methyl-D-aspartate (NMDA) receptors in the brain. By blocking these receptors, esketamine triggers a rapid release of glutamate, which is the brain’s primary excitatory neurotransmitter. This process promotes neuroplasticity, helping the brain grow new synaptic connections and repair damaged neural pathways.

Understanding these complex brain chemistry balances can be compared to mastering water chemistry basics: both require precise equilibrium to function correctly.

TMS, on the other hand, does not introduce any chemical substances into the body. Instead, it relies on electromagnetic induction. A coil placed on the scalp generates focused magnetic fields that pass painlessly through the skull. These magnetic fields induce small electrical currents in the prefrontal cortex, depolarizing neurons and stimulating activity in underactive brain regions. This physical stimulation helps restore normal functional connectivity across wider brain networks.

What are the employer and lifestyle considerations?

Because both treatments require regular visits to a medical facility, patients must plan for how their therapy will affect their professional and personal life. From an employer review standpoint, the direct impact on a patient’s daily routine is a key consideration.

Employer acceptance and workplace safety

Because Spravato can cause temporary cognitive impairment and sedation, patients are strictly prohibited from driving, operating machinery, or participating in safety-sensitive tasks until the day after their session. Employees must coordinate with their employers to secure necessary accommodations for these weekly or biweekly sessions.

The safety guidelines associated with this treatment are highly rigid. Regulatory bodies emphasize the importance of cognitive fitness in the workplace, and clinical staff must ensure that patients have a designated driver to take them home after every session.

With TMS, the impact on workplace safety is minimal. Because the treatment is non-systemic and does not involve sedation, patients can drive themselves to and from the clinic. They can return to their normal work duties immediately following their 20 to 40 minute session. This makes it an appealing option for individuals who cannot take extended leave from their jobs.

Coordination of care

To ensure the best possible outcomes, patients should make sure their treatment is coordinated by a clinical team that understands both pharmacological and non-pharmacological interventions. By integrating clinical visits with therapeutic support, patients can establish a stable foundation for long-term recovery.

Frequently Asked Questions

What are the main differences between Spravato vs TMS?

When comparing Spravato vs TMS, patients must evaluate both the pharmacological mechanism and the session duration. Ultimately, choosing Spravato vs TMS depends on whether you prefer a nasal spray with monitoring or a non-invasive electromagnetic treatment.

Is Spravato covered by health insurance?

Yes, because Spravato is FDA approved, it is covered by many major commercial insurance plans and Medicare for treatment-resistant depression. However, patients must meet specific clinical prerequisites, such as having tried multiple oral antidepressants without success, and the clinic must be REMS certified.

Can I drive myself home after a TMS session?

Yes, you can drive yourself home immediately after a TMS session. Because TMS is non-invasive and does not involve any anesthesia, sedation, or systemic medication, there are no driving restrictions or cognitive impairments associated with the procedure.

How long does a typical Spravato session last?

A typical Spravato session lasts at least two hours. While the actual self administration of the nasal spray takes only a few minutes, federal safety regulations require a mandatory two hour post dose observation period to monitor blood pressure and manage potential side effects.

What does a TMS session feel like?

During a TMS session, you will feel a tapping sensation on your scalp, which is often compared to a woodpecker gently tapping on your head. You will also hear a clicking sound. Most patients find the sensation tolerable, and any minor discomfort typically resolves within the first week of treatment.

Can I receive both Spravato and TMS at the same time?

While some advanced clinical protocols explore the sequential use of these therapies, they are typically administered as separate, distinct courses of treatment. Your clinical psychiatric team will evaluate your symptoms to determine which treatment should be prioritized.

Conclusion

In conclusion, evaluating Spravato vs TMS requires careful clinical oversight. Both paths offer a breakthrough, so discussing Spravato vs TMS with your psychiatrist is the best way to determine your treatment plan. By looking at the clinical benefits, the time commitments, and the administrative protocols of each option, you can choose the pathway that best aligns with your health goals. Whether you choose a pharmacological treatment that promotes neuroplasticity or a non-invasive treatment that stimulates brain activity, taking this proactive step is a major milestone on your journey toward recovery.

Disclaimer: The information provided here is for informational purposes only and should not be considered professional advice. Always seek guidance from a qualified professional before making decisions based on this content.